Sōlaria Biō

Sōlaria Biō develops synbiotic medical foods from microbial strains found in fresh fruits, vegetables, and fermented foods. Its discovery platform pairs a proprietary biobank with machine-learning models that predict strain function to build targeted, condition-specific products.

Its lead product, Bōndia, is a clinically studied bone-health synbiotic medical food validated in a randomized, placebo-controlled trial for the dietary management of bone loss, and a second synbiotic asset is in development for joint health. The company differentiates on clinical rigor, holding its products to medical-food standards rather than ordinary dietary-supplement norms, and it targets consumers seeking clinically validated bone and joint health support.